now the share price is 0.17 cents from your target. day to day price is not what you or i am looking at! on top of that tax loss selling is going on in the last few weeks.
We are looking at long term thing, and yes as you said in the past that company will be never be able to survive, it may be true. It may also be true that it will be very successul company. All we are debating here is the product and it's potential. your comparision of LAVIV with Sculptra is flawed just because they both are long term product.
An investor with your experience should not invoke the share price (either up or down) to shore up your position. It is always the last desperate step in a debate and it shows the limit of your knowledge. Too many people are as uninformed about laViv as you are. But that's why this is an opportunity for investors who understand the science.